A Phase 1b Study of Oral AS-1763 in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non Hodgkin Lymphoma

Protocol No
CARNABIOSCIENCES-C1763102
Phase
I
Summary

This project is being done to find out the maximum dose of AS-1763 that can be given safely and to find the bet dose for future research studies. It will also test the safety and how much AS-1763 is present in the blood, and for how long AS-1763 stays in the blood.

Description
A Phase 1b Study of Oral AS-1763 in Patients with CLL/SLL or NHL
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL